Latest Breaking News On - Avitide inc - Page 1 : comparemela.com
Form 8-K REPLIGEN CORP For: Aug 02
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Biotech startup sells for $150M
concordmonitor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from concordmonitor.com Daily Mail and Mail on Sunday newspapers.
Valley News - Biotech startup sells for $150 million
vnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vnews.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
LEBANON, N.H., Feb. 4, 2021 /PRNewswire/ Avitide, Inc. the industry leader in the discovery and development of affinity purification chromatography resins, announced that it has finalized the development of an affinity bioprocess resin for the purification of recombinant COVID-19 vaccines. The AVIPure
®-COV2S resin delivers outstanding performance as a capture resin for the majority of recombinant COVID-19 vaccines.
The AVIPure
®-COV2S resin is based on an affinity ligand that is highly selective to the receptor binding domain within the SARS-CoV-2 virus spike protein. The receptor binding domain is a central component within all recombinant COVID-19 vaccine developers strategies to elicit protective immune responses. Given the selectivity of the AVIPure